Loading company…
Pharm-Olam, LLC is a global contract research organization that supports biotech clinical development and regulatory approval.
Founded in 1994 and headquartered in Houston, US, Pharm-Olam, LLC offers regulatory strategy, clinical trial design, biostatistical programming, data management and post-marketing surveillance, mainly for small and mid-sized biotech firms in oncology, infectious diseases, neuroscience and rare diseases. It is paid through project-based and retainer fees. The company merged with CATO SMS in January 2022, and its most recent deal was on January 5, 2022. Listed stage: Seed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in